Skip to main content

Table 1 Effect of oxaliplatin on morphometry of L5 DRG neurons with immunoreactivity for pNF-H, parvalbumin, NF-M or NF-H.

From: Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue

  

Frequency of Immunoreactive Cells (%)

Mean Cell Body Area of Immunoreactive Cells (μm2)

Frequency of Small Cells (%)

Frequency of Medium Cells (%)

Frequency of Large Cells (%)

pNF-H

Control

21.0 ± 1.9

1259 ± 36

17.2 ± 1.7

67.2 ± 1.8

15.6 ± 2.3

 

Oxaliplatin

5.2 ± 0.3

696 ± 47

59.7 ± 3.8

39.5 ± 3.3

0.82 ± 0.5

 

Percent change

-75%

-45%

247%

-41%

-95%

 

P

<0.0002

<0.0001

<0.0001

<0.0005

<0.001

Parvalbumin

Control

17.4 ± 1.9

1042 ± 31

40.2 ± 1.9

44.6 ± 1.8

15.5 ± 2.9

 

Oxaliplatin

18.2 ± 4.2

739 ± 75

59.3 ± 12

37.2 ± 5.7

2.9 ± 2.2

 

Percent change

4.6%

-29%

49%

-17%

-81%

 

P

0.82

0.047

0.09

0.35

0.008

NF-M

Control

41.7 ± 4.0

997 ± 29

32.2 ± 2.2

63.6 ± 3.3

4.2 ± 1.6

 

Oxaliplatin

41.4 ± 4.6

888 ± 21

39.4 ± 4.5

59.0 ± 4.8

1.6 ± 0.3

 

Percent change

-1%

-11%

22%

-7%

-62%

 

P

0.96

0.038

0.22

0.47

0.19

NF-H

Control

96.0 ± 0.9

1068 ± 42

38.8 ± 6.8

46.0 ± 7.4

15.2 ± 0.8

 

Oxaliplatin

95.9 ± 1.0

765 ± 24

58.9 ± 1.8

37.4 ± 1.4

3.6 ± 0.6

 

Percent change

0%

-28%

52%

-19%

-76%

 

P

0.93

0.0033

0.045

0.32

<0.001

  1. Animals were treated with oxaliplatin or drug vehicle alone (control group) twice per week for 8 weeks. Values represent the mean and standard error of the mean for 4 to 5 animals/group.